insights_auto
Nega NVV1 oshdi 5,23%?
Batafsil oʻrganishchevron_right
NVV1:FRA
Novavax Inc
10,06 €
arrow_upward
+5,23%(+0,50) 1K
21-okt, 22:00:00 (GMT+2) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoNVV1 tikeri uchun statistika yaratilmoqda...
Ochish
10,20 €
Yuqori
10,20 €
Past
9,84 €
Bozor kapitali
1,82Â mlrd
Oʻrtacha hajm
3,03Â ming
Hajmi
0,00
52 haftalik eng yuqori
11,84 €
52 haftalik eng past
5,41 €
Xodimlar soni
749
Ochish
10,20 €
Yuqori
10,20 €
Past
9,84 €
Bozor kapitali
1,82Â mlrd
Oʻrtacha hajm
3,03Â ming
Hajmi
0,00
52 haftalik eng yuqori
11,84 €
52 haftalik eng past
5,41 €
Xodimlar soni
749
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
1 kun oldin
3 Reasons NVAX is Risky and 1 Stock to Buy Instead
Yahoo Finance
·
2 kun oldin
Novavax (NVAX) Stock Declines While Market Improves: Some Information for Investors
Barron's
·
5 kun oldin
Why Moderna Stock, Novavax, and Revolution Medicines Are Slumping Today
24/7 Wall St.
·
5 kun oldin
Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady
Profil
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus, avian flu, shingles, Clostridioides difficile, and malaria.
Novavax develops proprietary immune-stimulating saponin-based immunologic adjuvants at a wholly owned Swedish subsidiary, Novavax AB. One of these, Matrix-M, is used in the Novavax COVID-19 vaccine. Wikipedia
Novavax Inc haqida
CEOJohn C. Jacobs
Xodimlar soni749
Asos solingan1987
Bosh ofislarGaithersburg, Maryland, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytnovavax.com